ArticleScientific reports2025
Outcomes of septic shock from urinary and non-urinary sources in nonagenarians and centenarians admitted to intensive care units.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Sesamoside Alleviates Inflammatory Response in Septic Shock-Associated Acute Liver Injury by Modulating the NF-κB/MAPK Signaling Pathway.Dose-response : a publication of International Hormesis SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although sepsis-related mortality has declined with advances in care, the incidence of septic shock is rising by 1-8% annually. As life expectancy increases, the ≥ 90-year-old population is projected to reach 10 million in the U.S. by 2050, highlighting septic shock as a growing public health burden. Despite urinary tract infections being a common cause, non-urinary sources may carry higher mortality. However, outcome data in nonagenarians and centenarians are limited. This study compares outcomes by infection source in ICU patients aged 90 years or older with septic shock. This retrospective study, approved by the Alfred Ethics Committee (No. 253/24), used de-identified data from the ANZICS Adult Patient Database (2010-2023), including nonagenarian and centenarian ICU patients with septic shock. Variables included demographics, comorbidities, frailty, severity scores, and 24-h biomarkers. Outcomes were mortality by infection source and length of stay. Propensity score matching ensured covariate balance. Time-dependent Cox models and AUROC analysis were used. Complete case analysis was performed, with p < 0.05 considered statistically significant. Among 1095 ICU patients aged ≥ 90 with septic shock, non-urinary tract infections were associated with significantly higher short-term mortality compared to urinary sources, even after propensity matching (300-day HR 1.348; p = 0.012). ICU mortality (15.7% vs. 8.6%) and hospital mortality (29.0% vs. 17.3%) were also higher in the non-urinary group. APACHE III score, but not age or SOFA score, predicted mortality. Urine output and arterial pH were the best mortality discriminators for non-urinary and urinary sources, respectively. Higher SOFA and APACHE III scores were linked to shorter hospital stays, but not ICU length of stay. In critically ill patients aged ≥ 90 with septic shock, infection source was an independent, time-dependent predictor of mortality. Non-urinary tract infections were associated with significantly higher mortality than urinary tract infections for the first 300 days, despite comparable illness severity. These findings underscore the prognostic importance of infection source and its role in early risk stratification, triage, and end-of-life planning. Simple physiological markers, including urine output and arterial pH, demonstrated additional discriminatory value. As the very elderly ICU population grows, integrating infection source and early physiological indicators into tailored prognostic tools is essential to guide individualized, efficient care in high-resource critical care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.